# FDA Inspection 1228856 - Piedmont Henry Hospital - February 01, 2024

Source: https://www.keypedia.com/records/fda_inspections/piedmont-henry-hospital/cb3fc280-9b4e-43fa-9987-346d1121f49a
Source feed: FDA_Inspections

> FDA Inspection 1228856 for Piedmont Henry Hospital on February 01, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228856
- Company Name: Piedmont Henry Hospital
- Inspection Date: 2024-02-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1165417 - 2022-03-21](https://www.keypedia.com/records/fda_inspections/piedmont-henry-hospital/4b57a6f4-c61b-4ca1-b363-8f240d82f963)
- [FDA Inspection 1076837 - 2019-01-09](https://www.keypedia.com/records/fda_inspections/piedmont-henry-hospital/d2e418d0-a820-46e8-b301-1530c50e91a3)
- [FDA Inspection 997989 - 2017-01-20](https://www.keypedia.com/records/fda_inspections/piedmont-henry-hospital/cbc07fa1-1f67-4dc6-95aa-c0ccc3434c3b)

Company: https://www.keypedia.com/companies/piedmont-henry-hospital/5b8c041a-924a-44a1-8572-2c97f9f63963

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d